2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Pain
11
Neoplasms
8
Cancer Pain
7
Pain, Postoperative
2
Pain, Intractable
2
Lymphoma, Follicular
2
Leukemia
2
Waldenstrom Macroglobulinemia
1
Vomiting
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stomatitis
1
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Surgery
1
Sleep Wake Disorders
1
Signs and Symptoms
1
Sezary Syndrome
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pathologic Processes
1
Pain Related to Cancer
1
Opioid-Related Disorders
1
Neurologic Manifestations
1
Interventions
Bevacizumab
4
Temozolomide
3
Irinotecan
3
Sorafenib
2
Radiosurgery
2
pembrolizumab
1
ibrutinib
1
Vorinostat
1
Valproic Acid
1
Transcranial Magnetic Stimulation
1
Therapeutics
1
Thalidomide
1
Surveys and Questionnaires
1
Standard of Care
1
Sildenafil Citrate
1
Radiotherapy
1
Pliability
1
Plasma Exchange
1
Palliative Care
1
Nivolumab
1
Morphine
1
Methadone
1
Lenalidomide
1
Laparoscopy
1
Immunoglobulins
1
Exercise
1
Equipment and Supplies
1
Eating
1
Cytidine Triphosphate
1
Clomipramine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurologic Manifestations
×
Methadone
×
Clear all
NCT04475029
2023-09-13
METAMORF
University of Aarhus
Phase NA
Completed
114 enrolled